盐酸曲马多、地佐辛、舒芬太尼、盐酸氢吗啡酮防治瑞芬太尼复合麻醉术后超敏痛的效果比较

摘要
图/表
参考文献(15)
相关文章 (8)

全文: PDF (0 KB) HTML (34 KB)
输出: BibTeX | EndNote (RIS)

摘要目的比较盐酸曲马多、地佐辛、舒芬太尼、盐酸氢吗啡酮四种药物在防治瑞芬太尼复合超敏痛中的临床效果。方法选取2015年3月～2017年6月在我院行妇科腹腔镜手术的157例ASAⅠ～Ⅱ级患者作为研究对象，对其临床资料进行回顾性分析，根据手术前所用预防瑞芬太尼痛觉超敏反应药物的不同分为A组（盐酸曲马多，34例）、B组（地佐辛，43例）、C组（舒芬太尼，39例）和D组（盐酸氢吗啡酮，41例）。比较四组患者的苏醒时间和拔管时间，拔管时的心率（HR）和平均动脉压（MAP），术后 15 min、1 h、2 h、4 h、8 h、16 h 及 24 h 的 VAS 评分和 Ramsay镇静评分以及术后拔管期间及术后24 h内的不良反应发生情况。结果D组的苏醒时间和拔管时间明显短于A组、B组和C组（P＜0.05），B组和C组的苏醒时间和拔管时间明显短于A组（P＜0.05）；B组和C组的苏醒时间和拔管时间比较，差异无统计学意义（P＞0.05）。D组患者拔管时的HR和MAP均明显低于A组、B组和C组（P＜0.05），B组和C组拔管时的HR和MAP均明显低于A组（P＜0.05）；B组和C组拔管时的HR和MAP比较，差异无统计学意义（P＞0.05）。 D 组术后 2～24 h的 VAS评分明显低于 A 组、B 组和 C 组（P＜0.05），B 组和 C 组术后 2～24 h的 VAS评分明显低于A组（P＜0.05）；B、C两组术后2～24 h的VAS评分比较，差异无统计学意义（P＞0.05）。D组术后15 min～2 h的Ramsay镇静评分明显优于A组、B组和C组（P＜0.05），B组和C组术后15 min～2 h的Ramsay镇静评分明显优于 A 组（P＜0.05）；B、C 两组术后 15 min～2 h 的 Ramsay镇静评分比较，差异无统计学意义（P＞0.05）。四组术后拔管期间及术后24 h内的不良反应发生率比较为A组＞B组＞C组＞D组，差异有统计学意义（P＜0.05）。结论在防治瑞芬太尼复合麻醉术后的超敏痛方面，盐酸氢吗啡酮效果最为明显，不影响患者的苏醒和拔管时间，同时不良反应发生率也最低，其次为地佐辛和舒芬太尼，两者效果相当，但舒芬太尼的术后不良反应发生率更低，盐酸曲马多的效果最差。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	华兵

关键词 ：瑞芬太尼, 痛觉超敏, 盐酸氢吗啡酮, 地佐辛, 舒芬太尼, 盐酸曲马多

Abstract：ObjectiveTo compare the clinical effect of Tramadol Hydrochloride,Dezocine,Sufentanil,Hydromorphone Hydrochloride in the prevention and treatment of hypersensitivity pain after Remifentanil combined anesthesia.Methods157 patients with ASA gradeⅠ-Ⅱ who underwent gynecological laparoscopic surgery in our hospital from March 2015 to June 2017 were enrolled in this study,according to the different drugs used before surgery,the patients were divided into group A(Tramadol Hydrochloride,34 cases),group B(Dezocine,43 cases),group C(Sufentanil,39 cases)and group D(Hydromorphone Hydrochloride,41 cases).The recovery time and extubation time,extubation heart rate (HR)and mean arterial pressure (MAP)were compared between the four groups,the VAS scores and Ranmsay sedation scores were compared between the four groups at 15 minutes,1 h,2 h,4 h,8 h,16 h and 24 h postoperatively,and the incidence of adverse reactions during and after extubation in 24 hours were compared.ResultsThe recovery time and extubation time of group D were significantly shorter than those of group A,group B and group C (P＜0.05),and those of group B and group C were significantly shorter than those of group A(P＜0.05),there was no significant difference between the group B and group C in the recovery time and extubation time (P＞0.05).The HR and MAP of extubation of group D were significantly lower than those of group A,group B and group C (P＜0.05),the HR and MAP of extubation of group B and group C were also significantly lower than those of group A (P＜0.05),and there was no significant difference between the group B and group C in the HR and MAP of extubation(P＞0.05).The VAS score at 2 hours to 24 hours after operation in group D were significantly lower than those of group A,group B and group C (P＜0.05),while those of group B and group C were significantly lower than those of group A (P＜0.05),there was no significant difference between group B and group C in the VAS score at 2 hours to 24 hours after operation (P＞0.05).The ramsay sedation scores at 15 minutes to 2 hours after operation in group D were obviously better than those of group A,group B and group C (P＜0.05),those of group B and group C were obviously better than that of group A (P＜0.05),there was no significant difference between group B and group C in the ramsay sedation scores at 15 minutes to 2 hours after operation(P＞0.05).The incidence of adverse reactions in the four groups after extubation and postoperative 24 h was group A＞group B＞group C＞group D,the differences were statistically significant(P＜0.05).ConclusionIn the prevention and treatment of Remifentanil after anesthesia,the effect of Hydromorphone Hydrochloride is the most obvious,it does not affect the recovery and extubation time of the patients,and the incidence of adverse reactions is also the lowest,followed by Dezocine and Sufentanil,both are quite effective,but the adverse effects of Sufentanil postoperative complication rate is lower,and Tramadol Hydrochloride is the worst.

Key words： Remifentanil Hypersensitivity Hydromorphone Hydrochloride Dezocine Sufentanil Tramadol Hydrochloride

引用本文:

华兵. 盐酸曲马多、地佐辛、舒芬太尼、盐酸氢吗啡酮防治瑞芬太尼复合麻醉术后超敏痛的效果比较[J]. 中国当代医药, 2018, 25(2): 115-118转122.
HUA Bing. Effect comparison of Tramadol Hydrochloride,Dezocine,Sufentanil,Hydromorphone Hydrochloride in the prevention and treatment of hypersensitivity pain after Remifentanil combined anesthesia. 中国当代医药, 2018, 25(2): 115-118转122.

链接本文:

http://dangdaiyiyao.com/CN/ 或 http://dangdaiyiyao.com/CN/Y2018/V25/I2/115

[1]	李燕，王国年，林鹰，等.NMDAR在瑞芬太尼引起痛觉过敏机制和防治的研究进展[J].现代生物医学进展，2015，15（6）：1148-1150.
[2]	方艳丽.地佐辛预防瑞芬太尼复合麻醉患者术后疼痛的临床价值[J].中国药物评价，2013，30（1）：17-18.
[3]	邵涛，胡海燕.地佐辛不同给药方式对瑞芬太尼复合麻醉术后苏醒期拔管及镇痛镇静效果的影响[J].实用药物与临床，2014，17（8）：996-1000.
[4]	杜奕鹏，姜凤鸣，崔瑞岑，等.右美托咪定复合曲马多预防瑞芬太尼复合麻醉患者术后痛觉过敏的效果[J].中华麻醉学杂志，2015，35（2）：249-250.
[5]	肖冬媛.舒芬太尼与曲马多治疗瑞芬太尼复合麻醉术后急性疼痛的效果分析[J].中国现代药物应用，2016，10（2）：138-140.
[6]	张郃，龙超，黎逢球，等.氢吗啡酮预防瑞芬太尼复合麻醉患者术后痛觉过敏的临床效果[J].临床麻醉学杂志，2014，30（10）：1030-1031.
[7]	张岩.喷他佐辛预防瑞芬太尼复合麻醉患者术后痛觉过敏的临床研究[J].徐州医学院学报，2015，35（1）：25-27.
[8]	王庚，吴新民.瑞芬太尼复合麻醉患者术后急性阿片类药物耐受的发生[J].中华麻醉学杂志，2014，27（5）：534-536.
[9]	李芸，李天佐，纪方，等.三种镇痛药抑制瑞芬太尼致痛觉过敏作用的比较[J].临床麻醉学杂志，2014，11（10）：130-131.
[10]	沈国容，冯继英，赵志斌.预注射氯胺酮或帕瑞昔布对瑞芬太尼麻醉后痛觉过敏的影响[J].临床麻醉学杂志，2014，4（10）：210-212.
[11]	孙建刚，吕国义.帕瑞昔布联合地佐辛抑制瑞芬太尼全静脉麻醉术后痛觉超敏[J].中华临床医师杂志，2013，7（4）：1441-1444.
[12]	韩桂彩.地佐辛预防瑞芬太尼复合麻醉患者术后疼痛的临床研究[J].中国医药指南，2014，12（1）：73-74.
[13]	裴洪友，李宇虹，邢彦杰.舒芬太尼防治瑞芬太尼复合麻醉术后急性疼痛[J].河北联合大学学报（医学版），2013，15（1）：56-57.
[14]	金璐，陈丽，张燕玲，等.不同麻醉药对瑞芬太尼诱发术后痛觉超敏的影响[J].现代生物医学进展，2016，16（9）：1615-1618.
[15]	樊顺克.氢吗啡酮预防瑞芬太尼复合麻醉患者术后痛觉过敏的临床研究[J].航空航天医学杂志，2017，28（4）：396-397.